History

AHN Biotechnologie GmbH is a prominent player in the life science industry, renowned for its innovative products and consistent growth. Established in 1999, the company was acquired by the Danish CAPP ApS in 2016, a company which itself was founded in 1984. CAPP moved its operations to Germany, where AHN is located, and in 2019, AHN Biotechnologie GmbH expanded its product range by acquiring Maxxline, a company with extensive experience in manufacturing plastic consumables for laboratories. AHN’s state-of-the-art production facility meets the rigorous requirements of top life science brands and distribution companies worldwide, while CAPP is a dependable supplier of liquid handling products that are both innovative and user-friendly, with a focus on premium quality. Maxxline’s cryoware products employ innovative production methods and prioritise the highest level of quality to meet the market’s demands for increased productivity and process reliability. With the recent facility extension in 2022, AHN Biotechnologie GmbH is well-positioned to continue its expansion and innovation in the industry.